Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | EFCAB10 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of EFCAB10 mRNA | CTD | PMID:31614463 | EFCAB10 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Efcab10 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of EFCAB10 mRNA | CTD | PMID:24780913 | EFCAB10 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Efcab10 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of EFCAB10 mRNA | CTD | PMID:25825206 | EFCAB10 | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of EFCAB10 intron | CTD | PMID:30157460 | EFCAB10 | Human | benzo[a]pyrene | decreases methylation | ISO | Efcab10 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased methylation of EFCAB10 promoter | CTD | PMID:27901495 | EFCAB10 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of EFCAB10 intron | CTD | PMID:30157460 | EFCAB10 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of EFCAB10 promoter | CTD | PMID:27901495 | EFCAB10 | Human | bisphenol A | decreases expression | ISO | Efcab10 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of EFCAB10 mRNA | CTD | PMID:25181051 | EFCAB10 | Human | bisphenol A | increases expression | ISO | Efcab10 (Mus musculus) | 6480464 | bisphenol A results in increased expression of EFCAB10 mRNA | CTD | PMID:32156529 | EFCAB10 | Human | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of EFCAB10 gene | CTD | PMID:31601247 | EFCAB10 | Human | bisphenol A | decreases expression | ISO | Efcab10 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of EFCAB10 mRNA | CTD | PMID:34585602 | EFCAB10 | Human | bisphenol A | increases methylation | ISO | Efcab10 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of EFCAB10 gene | CTD | PMID:28505145 | EFCAB10 | Human | carbon nanotube | decreases expression | ISO | Efcab10 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | EFCAB10 | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of EFCAB10 mRNA | CTD | PMID:27392435 | EFCAB10 | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of EFCAB10 mRNA | CTD | PMID:27392435 | EFCAB10 | Human | copper atom | increases expression | ISO | Efcab10 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of EFCAB10 mRNA | CTD | PMID:26033743 | EFCAB10 | Human | copper(0) | increases expression | ISO | Efcab10 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of EFCAB10 mRNA | CTD | PMID:26033743 | EFCAB10 | Human | Cuprizon | increases expression | ISO | Efcab10 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of EFCAB10 mRNA | CTD | PMID:26577399 | EFCAB10 | Human | GW 4064 | increases expression | ISO | Efcab10 (Mus musculus) | 6480464 | GW 4064 results in increased expression of EFCAB10 mRNA | CTD | PMID:26655953 | EFCAB10 | Human | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of EFCAB10 mRNA | CTD | PMID:28001369 | EFCAB10 | Human | mono(2-ethylhexyl) phthalate | affects expression | ISO | Efcab10 (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate affects the expression of EFCAB10 mRNA | CTD | PMID:21195148 | EFCAB10 | Human | Monobutylphthalate | affects expression | ISO | Efcab10 (Mus musculus) | 6480464 | monobutyl phthalate affects the expression of EFCAB10 mRNA | CTD | PMID:21195148 | EFCAB10 | Human | ozone | multiple interactions | ISO | Efcab10 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of EFCAB10 mRNA | CTD | PMID:34911549 | EFCAB10 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of EFCAB10 mRNA | CTD | PMID:22230336 | EFCAB10 | Human | permethrin | decreases expression | EXP | | 6480464 | Permethrin results in decreased expression of EFCAB10 mRNA | CTD | PMID:37047231 | EFCAB10 | Human | pirinixic acid | increases expression | ISO | Efcab10 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of EFCAB10 mRNA | CTD | PMID:20813756 | EFCAB10 | Human | propanal | increases expression | EXP | | 6480464 | propionaldehyde results in increased expression of EFCAB10 mRNA | CTD | PMID:26079696 | EFCAB10 | Human | titanium dioxide | decreases expression | ISO | Efcab10 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of EFCAB10 mRNA | CTD | PMID:23557971 | EFCAB10 | Human | vinclozolin | decreases expression | ISO | Efcab10 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of EFCAB10 mRNA | CTD | PMID:23555832 | |